Work

Prediction of adverse effects of doxorubicin based on pharmacokinetics and pharmacogenetics in patients with breast cancer

Year: 2024

Type: article

Abstract: Treatment with doxorubicin for breast cancer is frequently associated with various adverse effects that can be related to the drug plasma concentration. The latter may be modified by pharmacogenetic factors.

Source: Clinical pharmacology and therapy

DOI: 10.32756/0869-5490-2024-3-21-25

Authors: A.A. Bagdasaryan, E.V. Shikh, V.N. Drozdov, R.E. Kazakov, V.V. Smirnov

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4403208730

FWCI:

Cites:

Cited by:

Related to: 10